ResMed | RMD - Loan Capital


ResMed reported $403.92M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Ansell USD 638.5M 68.1M Jun/2025
Artivion USD 214.87M 669K Sep/2025
AtriCure USD 61.86M 0 Dec/2025
Baxter International USD 9.47B 726M Dec/2025
Cochlear AUD 193.5M 10M Jun/2025
Cooper Companies USD 2.46B 26.1M Sep/2025
CSL USD 10.69B 1.37B Jun/2025
Dexcom USD 1.24B 53.6M Dec/2025
Edwards Lifesciences USD 598.2M 200K Sep/2025
Fisher Paykel Healthcare NZD 62.6M 4.3M Dec/2025
Globus Medical USD 427K 254K Sep/2025
Haemonetics USD 919.99M 406K Dec/2025
Hologic USD 2.5B 2.1M Dec/2025
Idexx Laboratories USD 374.84M 17K Dec/2025
Inogen USD 0 0 Jun/2022
Insulet USD 930.8M 4.1M Dec/2025
Integra LifeSciences USD 1.86B 63.76M Dec/2025
Intuitive Surgical USD 0 0 Mar/2025
Masimo USD 559.1M 39.6M Sep/2025
Medtronic USD 27.62B 1.45B Sep/2025
Philips EUR 6.93B 303M Dec/2025
Ramsay Health Care AUD 5.46B 5.23B Jun/2025
ResMed USD 403.92M 4.74M Dec/2025
Sigma Healthcare AUD 1.88B 1.75B Dec/2025
Sonic Healthcare AUD 4.19B 333.39M Dec/2024
Steris USD 1.9B 1.1M Dec/2025
Teleflex USD 2.54B 30.06M Dec/2025
Thermo Fisher Scientific USD 35.85B 4B Dec/2025